David A. Roth
2015 - Syros Pharmaceuticals
In 2015, David A. Roth earned a total compensation of $1.5M as Chief Medical Officer at Syros Pharmaceuticals.
Compensation breakdown
| Option Awards | $1,437,272 |
|---|---|
| Salary | $26,064 |
| Total | $1,463,336 |
Roth received $1.4M in option awards, accounting for 98% of the total pay in 2015.
Roth also received $26.1K in salary.
Rankings
In 2015, David A. Roth's compensation ranked 6,107th out of 13,638 executives tracked by ExecPay. In other words, Roth earned more than 55.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,107 out of 13,638 | 55th |
Division Manufacturing | 2,283 out of 5,190 | 56th |
Major group Chemicals And Allied Products | 822 out of 1,854 | 56th |
Industry group Drugs | 657 out of 1,528 | 57th |
Industry Pharmaceutical Preparations | 512 out of 1,182 | 57th |
Source: SEC filing on April 25, 2017.
Roth's colleagues
We found two more compensation records of executives who worked with David A. Roth at Syros Pharmaceuticals in 2015.
News
Syros Pharmaceuticals CEO Nancy Simonian's 2022 pay rises 12% to $3.5M
April 21, 2023
Syros Pharmaceuticals CEO Nancy Simonian's 2021 pay jumps 23% to $3.1M
April 21, 2022
Syros Pharmaceuticals CEO Nancy Simonian's 2020 pay falls 30% to $2.5M
April 29, 2021
Syros Pharmaceuticals CEO Nancy Simonian's 2019 pay rises 19% to $3.6M
April 28, 2020
Syros Pharmaceuticals CEO Nancy Simonian's 2018 pay jumps 36% to $3M
April 25, 2019